Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)-Reference-Cited by-同舟云学术

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)

Published:2019-04-09 Issue:6 Volume:8 Page:2730-2739
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Furqan Muhammad¹^ORCID,Snyders Travis P.¹,Saqlain Mohammed U.¹,Mott Sarah L.²,Laux Douglas¹,Snow Anthony³,Anderson Carryn M.⁴,Watkins John M.⁴,Clamon Gerald H.¹

Affiliation:

1. Department of Internal Medicine University of Iowa Hospitals and Clinics Iowa City Iowa

2. Biostatistics Core Holden Comprehensive Cancer Center University of Iowa Hospitals and Clinics Iowa City Iowa

3. Department of Pathology University of Iowa Hospitals and Clinics Iowa City Iowa

4. Department of Radiation Oncology University of Iowa Hospitals and Clinics Iowa City Iowa

Funder

Holden Comprehensive Cancer Center, University of Iowa

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2139

Reference41 articles.

1. Cancer statistics, 2018

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

3. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

4. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

5. Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells—an in-vitro study;Head & Face Medicine;2022-06-29

2. Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches;Journal of Personalized Medicine;2022-05-24

3. Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy;Journal of Controlled Release;2022-03

4. Kurative Radiochemotherapie von Kopf-Hals-Tumoren;TumorDiagnostik & Therapie;2022-03

5. Study to evaluate the acute toxicities and response to concurrent chemoradiotherapy with weekly cisplatin versus cisplatin and paclitaxel in locally advanced head-and-neck cancer;Journal of Radiation and Cancer Research;2022